EQT Offers to Buy Recipharm of Sweden in $2.1 Billion Deal
EQT Offers to Buy Recipharm of Sweden in $2.1 Billion Deal Bloomberg 12/14/2020 Charles Daly © Bloomberg Recipharm shares rose as much as 23% to 220.20 kronor, near the bid price, in Stockholm Monday morning. (Bloomberg) -- Private equity firm EQT AB agreed to buy Swedish pharmaceuticals company Recipharm AB for $2.1 billion, marking the latest in a wave of drug industry acquisitions. EQT said Monday it’s offering shareholders 220 kronor in cash per share, 23% more than Friday’s closing price. Recipharm is a 25-year-old company that specializes in outsourcing contract...
Source: msn.com